Revex Articles
Ph II/III trial of Somaxon's nalmefene still recruiting
13 February 2006
Somaxon gets N American rights to Biotie's oral nalmefene
22 November 2004
NCEs In 1995: A Good Range Of Novel Drugs
29 January 1996
US FDA Approving Fewer NMEs, But Faster, In 1995
11 September 1995
BOC's Revex To Be Launched Soon?
8 May 1995
Showing 1-5 of 5 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
